Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies-Reference-Cited by-同舟云学术

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies

Published:2016-04-29 Issue:7 Volume:23 Page:1248-1253
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Draak T. H. P.¹,Gorson K. C.²,Vanhoutte E. K.³,van Nes S. I.⁴,van Doorn P. A.⁵,Cornblath D. R.⁶,van den Berg L. H.⁷,Faber C. G.¹^ORCID,Merkies I. S. J.¹⁸,

Affiliation:

1. Department of Neurology; University Medical Centre Maastricht; Maastricht The Netherlands

2. Department of Neurology; St Elizabeth's Medical Centre; Tufts University School of Medicine; Boston MA USA

3. Department of Clinical Genetics; Maastricht University Medical Centre; Maastricht The Netherlands

4. Department of Neurology; Havenziekenhuis; Rotterdam The Netherlands

5. Department of Neurology; Erasmus Medical Centre Rotterdam; Rotterdam The Netherlands

6. Department of Neurology; Johns Hopkins School of Medicine; Baltimore MD USA

7. Department of Neurology; Rudolf Magnus Institute of Neuroscience University Medical Centre Utrecht; Utrecht The Netherlands

8. Department of Neurology; Spaarne Hospital; Hoofddorp The Netherlands

Funder

GBS-CIDP Foundation International

Talecris Talents program

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13025/fullpdf

Reference29 articles.

1. (USDHHS) UDoHaHS Guidance for industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory%20Information/Guidances/UCM193282.pdf

2. The missing voice of patients in drug-safety reporting;Basch;N Engl J Med,2010

3. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels;Willke;Control Clin Trials,2004

4. Combining scores from different patient reported outcome measures in meta-analyses: when is it justified?;Puhan;Health Qual Life Outcomes,2006

5. PRO development: rigorous qualitative research as the crucial foundation;Lasch;Qual Life Res,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment response in patients with clinical and supportive laboratory features of chronic inflammatory demyelinating polyneuropathy without demyelinative findings on nerve conduction studies: A retrospective study;Muscle & Nerve;2024-07-03

2. Outcome measures in pediatric chronic inflammatory demyelinating polyradiculoneuropathy;Muscle & Nerve;2024-03-04

3. In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center;Transplant Immunology;2023-12

4. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome;European Journal of Neurology;2023-10-10

5. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome;Journal of the Peripheral Nervous System;2023-10-10